We paid $9,200 for the ultimate checkup. Worth it?

Key wellness + self-care / prevention strategies highlighted

• Use early detection to catch “silent killers”

  • Examples of clinic-style screening: full-body MRI, low-dose CT, DEXA, ultrasound, EKG, advanced blood panels, plus whole genome sequencing.
  • Emphasis on imaging + labs interpreted together in clinical context rather than relying on an isolated scan report.

• Be cautious with blanket full-body MRI for everyone

  • The video highlights controversy: false positives/false negatives can trigger anxiety and more invasive procedures (e.g., biopsies) that can cause harm.
  • Key takeaway: focus on risk/benefit and appropriate follow-up—not scanning “because it’s available.”

• Integrate genomics with medical decision-making

  • Whole genome sequencing is presented as more actionable than consumer tests alone (e.g., 23andMe is not full genome sequencing).
  • Genetic information is used to:
    • estimate disease risk (e.g., Alzheimer’s, diabetes, LDL, MS, clot risk)
    • guide screening choices
    • inform pharmacogenomics (drug selection based on how you metabolize meds)

• Alzheimer’s dementia risk reduction (actionable prevention claims)

  • Annual flu vaccination: presented as a major risk reducer (claim: ~50% reduction in Alzheimer’s risk from large studies).
  • Statins: discussed as potentially beneficial—especially for APOE4 carriers (claim: ~40% reduction in odds for dementia in APOE4 carriers).
  • Nutrition/lifestyle cautions tied to APOE genetics:
    • Alcohol: moderate alcohol may be tolerated for some variants (e.g., APOE3), but any alcohol is framed as harmful for APOE4.
    • Diabetes + APOE4: described as dramatically increasing risk.

• Precision nutrition / metabolic awareness

  • Genetics can explain tendencies and guide behavior:
    • Iron overload susceptibility (hemochromatosis variants): described as potentially pro-aging via iron’s oxidative effects.
  • Suggested behavior aligned with findings: blood donation to manage iron levels (with emphasis that it may help reduce liver/pancreas iron).
  • Caution against red meat/hem-iron as a driver of excess iron (as discussed).

• Prevent downstream harm from over-testing

  • When incidental findings occur (e.g., prostate lesions), the approach described is:
    • hesitate on biopsy when findings suggest low-grade risk
    • act when findings appear high-grade or PSA trends are concerning
  • Goal: optimize the risk ratio to avoid unnecessary invasive procedures.

• Use polygenic risk scores to shape preventive priorities

  • Polygenic risk scoring is discussed as a way to flag elevated risks across many conditions (including some neuropsychiatric and autoimmune risks).
  • Examples given:
    • elevated schizophrenia risk → guidance to avoid cannabis (especially in adolescence) and caution with psychedelics/stimulant misuse
    • elevated LDL and diabetes risk → implied need for earlier lifestyle/medical attention
    • MS risk → awareness of Epstein-Barr virus exposure and vitamin D/latitude associations (epidemiology discussed)

• Pharmacogenomics (“choose meds you metabolize well”)

  • Recommendation emphasized: provide pharmacogenomic results to prescribers so drugs can be selected/titrated based on whether someone is a normal, fast, or slow metabolizer for specific medications.

• Lifestyle modifications based on results (promised for next episode)

  • Findings prompted changes to diet, exercise, and overall lifestyle, with the next episode focused on what those changes were.

---

Presenters / sources mentioned

• Dr. Wayi Woo Ha (CEO, longevity scientist; Human Longevity, Inc.)
• Eric Toppel (cardiologist; author of Super Agers)
• Deborah Cohen (medical journalist; author of Bad Influence: How the Internet Hijacked Our Health)
• Dr. Pearson (interviewed; involved in interpreting results)
• Barry Castleith (Sloan Kettering mentioned in relation to commentary on Steve Jobs)
• Chris (speaker/host who discusses his story and results)
• Tony (participant; discussed in genetics/Alzheimer’s and iron context)
• Miguel (mentioned as another participant whose results reportedly were less alarming)
• Grail (brand mentioned: “multi-cancer early detection test from Grail”)
• American College of Radiology (recommends against full-body MRI screening)
• Sloan Kettering (mentioned via Barry Castleith)